Free Trial
NASDAQ:UTMD

Utah Medical Products Q4 2023 Earnings Report

Utah Medical Products logo
$63.30 -0.57 (-0.89%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$63.31 +0.01 (+0.02%)
As of 10/3/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Utah Medical Products EPS Results

Actual EPS
$1.18
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Utah Medical Products Revenue Results

Actual Revenue
$12.33 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Utah Medical Products Announcement Details

Quarter
Q4 2023
Time
N/A
Conference Call Date
Tuesday, January 30, 2024
Conference Call Time
5:00AM ET

Upcoming Earnings

Utah Medical Products' Q3 2025 earnings is scheduled for Monday, October 27, 2025, with a conference call scheduled on Tuesday, October 28, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Utah Medical Products Earnings Headlines

URGENT: The Market's 3 Red Flags Are Flashing
The warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gold price (signaling fear), and escalating geopolitical risk. A sharp correction might happen tomorrow, and most investors will be caught off guard. Your portfolio is currently exposed.tc pixel
Utah Medical Products Reports Q2 Decline
See More Utah Medical Products Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Utah Medical Products? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Utah Medical Products and other key companies, straight to your email.

About Utah Medical Products

Utah Medical Products (NASDAQ:UTMD) (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂). Utah Medical Products also offers solutions for interventional pulmonology and endoscopy, providing healthcare professionals with a broad range of devices designed, tested and manufactured under clean‐room conditions to meet stringent regulatory standards.

Utah Medical Products serves hospitals, surgical centers and long‐term care facilities through a combination of direct sales and an international network of distributors. Its customer base spans North America, Europe, Asia and Latin America, reflecting ongoing efforts to expand its geographic footprint and respond to global demand for reliable airway management and monitoring technologies.

The company is managed by an experienced leadership team with backgrounds in medical device engineering, regulatory affairs and quality assurance. This team guides Utah Medical Products in advancing its product pipeline, maintaining compliance with international standards and ensuring timely delivery of sterile, single‐use devices to healthcare providers worldwide.

View Utah Medical Products Profile

More Earnings Resources from MarketBeat